Anthony W Kim

Summary

Affiliation: Yale University
Country: USA

Publications

  1. doi request reprint Innovations in thoracic surgery
    Anthony W Kim
    Section of Thoracic Surgery, Yale School of Medicine, New Haven, Connecticut 06520, USA
    Curr Opin Anaesthesiol 26:13-9. 2013
  2. doi request reprint Additional pulmonary nodules in the patient with lung cancer: controversies and challenges
    Anthony W Kim
    Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, 330 Cedar Street, BB 205, New Haven, CT 06520, USA
    Clin Chest Med 32:811-25. 2011
  3. pmc Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer
    Anthony W Kim
    Section of Thoracic Surgery, Department of Therapeutic Radiology and Radiation Oncology, Cancer Outcomes, Public Policy, and Effectiveness Research COPPER Center, Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, Connecticut 06520, USA
    Ann Thorac Surg 94:895-901. 2012
  4. doi request reprint Lymph node drainage patterns and micrometastasis in lung cancer
    Anthony W Kim
    Section of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Semin Thorac Cardiovasc Surg 21:298-308. 2009
  5. doi request reprint Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer
    Anthony W Kim
    Section of Thoracic Surgery, Yale University School of Medicine, New Haven, CT 06520, United States
    Lung Cancer 71:186-90. 2011
  6. doi request reprint An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer
    Anthony W Kim
    Section of Thoracic Surgery, School of Medicine, Yale University, New Haven, Conn 06520, USA
    J Thorac Cardiovasc Surg 143:55-63. 2012
  7. pmc Use of new treatment modalities for non-small cell lung cancer care in the Medicare population
    Michael T Vest
    Department of Internal Medicine, Section of Pulmonary and Critical Care Medicine, Yale School of Medicine, New Haven, CT 06520, USA
    Chest 143:429-35. 2013
  8. pmc Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancer
    Michael T Vest
    Department of Internal Medicine, Section of Pulmonary and Critical Care Medicine, Yale Comprehensive Cancer Center, New Haven, Connecticut, USA
    J Thorac Oncol 7:188-95. 2012
  9. doi request reprint Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients
    Anthony W Kim
    Section of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut
    Ann Thorac Surg 92:233-41; discussion 241-3. 2011
  10. doi request reprint Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry
    Usman Ahmad
    Section of Thoracic Surgery, Department of Epidemiology, Yale University School of Public Health, New Haven, Connecticut 06520 8062, USA
    Ann Thorac Surg 94:935-40; discussion 940-1. 2012

Detail Information

Publications16

  1. doi request reprint Innovations in thoracic surgery
    Anthony W Kim
    Section of Thoracic Surgery, Yale School of Medicine, New Haven, Connecticut 06520, USA
    Curr Opin Anaesthesiol 26:13-9. 2013
    ....
  2. doi request reprint Additional pulmonary nodules in the patient with lung cancer: controversies and challenges
    Anthony W Kim
    Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, 330 Cedar Street, BB 205, New Haven, CT 06520, USA
    Clin Chest Med 32:811-25. 2011
    ..This article focuses on the malignant additional pulmonary nodule in the same lobe as the known primary tumor, in a different lobe in the same lung as the known primary tumor, and in the contralateral lung...
  3. pmc Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer
    Anthony W Kim
    Section of Thoracic Surgery, Department of Therapeutic Radiology and Radiation Oncology, Cancer Outcomes, Public Policy, and Effectiveness Research COPPER Center, Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, Connecticut 06520, USA
    Ann Thorac Surg 94:895-901. 2012
    ..However it is unclear how race, clinical, and hospital characteristics affect the surgical approach among patients undergoing resection...
  4. doi request reprint Lymph node drainage patterns and micrometastasis in lung cancer
    Anthony W Kim
    Section of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Semin Thorac Cardiovasc Surg 21:298-308. 2009
    ..This manuscript reviews the patterns of lymph node drainage from a historical and current perspective to facilitate an understanding of the existing knowledge with respect to skip metastasis and micrometastasis...
  5. doi request reprint Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer
    Anthony W Kim
    Section of Thoracic Surgery, Yale University School of Medicine, New Haven, CT 06520, United States
    Lung Cancer 71:186-90. 2011
    ..Lack of XOR expression is associated with unfavorable clinical outcomes. The objective of this study was to correlate XOR expression with prognosis in surgically resected non-small cell lung cancer (NSCLC)...
  6. doi request reprint An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer
    Anthony W Kim
    Section of Thoracic Surgery, School of Medicine, Yale University, New Haven, Conn 06520, USA
    J Thorac Cardiovasc Surg 143:55-63. 2012
    ..Pneumonectomy after neoadjuvant therapy remains controversial...
  7. pmc Use of new treatment modalities for non-small cell lung cancer care in the Medicare population
    Michael T Vest
    Department of Internal Medicine, Section of Pulmonary and Critical Care Medicine, Yale School of Medicine, New Haven, CT 06520, USA
    Chest 143:429-35. 2013
    ..The adoption of these techniques and their impact on access to cancer care among Medicare beneficiaries with stage I NSCLC are unknown...
  8. pmc Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancer
    Michael T Vest
    Department of Internal Medicine, Section of Pulmonary and Critical Care Medicine, Yale Comprehensive Cancer Center, New Haven, Connecticut, USA
    J Thorac Oncol 7:188-95. 2012
    ..Studies have suggested that invasive mediastinal staging is underutilized, although practice patterns have not been rigorously evaluated...
  9. doi request reprint Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients
    Anthony W Kim
    Section of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut
    Ann Thorac Surg 92:233-41; discussion 241-3. 2011
    ..This study evaluated patient survival after neoadjuvant chemoradiation and anatomic pulmonary resections for locoregionally advanced NSCLC...
  10. doi request reprint Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry
    Usman Ahmad
    Section of Thoracic Surgery, Department of Epidemiology, Yale University School of Public Health, New Haven, Connecticut 06520 8062, USA
    Ann Thorac Surg 94:935-40; discussion 940-1. 2012
    ..To compare outcomes of lung transplantation for advanced BAC, we studied this population in a compulsory, prospectively maintained database...
  11. doi request reprint Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomes
    Henry S Park
    Section of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Ann Thorac Surg 93:372-9. 2012
    ..Some previous analyses comparing VATS vs open lobectomy outcomes have been limited by inaccuracies in patient cohort identification...
  12. doi request reprint Long-term survival after lung resection for non-small cell lung cancer with circulatory bypass: a systematic review
    Ashok Muralidaran
    Section of Thoracic Surgery, School of Medicine, Yale University, New Haven, Conn 06520, USA
    J Thorac Cardiovasc Surg 142:1137-42. 2011
    ..The objective of this study was to systematically review the long-term survival associated with the published studies dealing with the performance of lung resections for non-small cell lung cancer using circulatory bypass...
  13. doi request reprint Stereotactic body radiotherapy for central lung tumors
    Bryan P Rowe
    Department of Therapeutic Radiology, Yale University School of Medicine, Yale Cancer Center, New Haven, Connecticut 06520, USA
    J Thorac Oncol 7:1394-9. 2012
    ..The primary purpose of this study was to assess toxicity in patients with central lesions treated with SBRT at our institution, the majority of whom were treated with four fractions...
  14. doi request reprint Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database
    Amy C Moreno
    Section of Thoracic Surgery, Yale School of Medicine, New Haven, Connecticut
    J Surg Res 184:10-8. 2013
    ..The objective of this study was to evaluate the effect of surgery in the presence andĀ absence of neoadjuvant radiation (NRT) on survival of patients with T3N0 >7-cm NSCLCs...
  15. doi request reprint Pulmonary resections following prior definitive chemoradiation therapy are associated with acceptable survival
    Gregory A Kuzmik
    Yale School of Medicine, New Haven, CT 06520, USA
    Eur J Cardiothorac Surg 44:e66-70. 2013
    ..The benefits of salvage resection for lung cancer recurrence following high-dose curative-intent chemoradiation therapy are unclear. We assessed survival after salvage lung resection following definitive chemoradiation...
  16. doi request reprint Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer?
    Daniel J Boffa
    Department of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut, USA
    J Thorac Oncol 5:1779-83. 2010
    ..However, the staging system revision was not designed to evaluate treatment, and attempts to make parallel adjustments in treatment plans may not be justified...